Human pre-α-inhibitor is a positive acute-phase protein that is more susceptible than inter-α-inhibitor to proteolysis by stimulated neutrophils

European Journal of Clinical Investigation

Volumn 30, Issue 1, 2000, Pages 79-86

  Mizon, C ^a   Queyrel, V ^b   Balduyck, M ^a   Drobecq, H ^a,b   Hachulla, E ^b   Mizon, Jacques ^a  

^a UNIV LILLE   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Elastase; Enzyme immunoassay; Inter inhibitor; Polymorphonuclear leucocytes; Pre inhibitor

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; ELASTASE; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN; PRE ALPHA INHIBITOR; SERINE PROTEINASE INHIBITOR; ULINASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-GLOBULINS; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEUTROPHILS; PROTEIN PRECURSORS; RABBITS; TRYPSIN INHIBITORS;

EID: 0033963550     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00594.x     Document Type: Article

References (25)

1. 1 Salier JP, Rouet P, Raguenez G, Daveau M. The inter-α-inhibitor family: from structure to regulation. Biochem J 1996;315:1-9
2. 2 Daveau M, Rouet P, Scotte M et al. Human inter-α-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins. Biochem J 1993;292:485-92
3. 3 Albani D, Balduyck M, Mizon C, Mizon J. Inter-α-inhibitor as marker for neutrophil proteinase activity: an in vitro investigation. J Lab Clin Med 1997;130:339-47
4. 4 Witte J, Jochum M, Scherer R, Schramm W, Hochstrasser K, Fritz H. Disturbances of selected plasma proteins in hyper-dynamic septic shock. Intens Care Med 1982;8:215-22
5. 5 Chawla RK, Rausch DJ, Miller FW, Vogler WR, Lawson DH. Abnormale profile of serum proteinase inhibitors in cancer patients. Cancer Res 1984;44:2718-23
6. 6 Viedma JA, Pèrez-Mateo M, Agullo J, Dominguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994;35:822-7
7. 7 Morelle W, Capon C, Balduyck M et al. Chondroitin sulphate covalently cross-links the three polypeptide chains of inter-α-trypsin inhibitor. Eur J Biochem 1994;221:881-8
8. 8 Enghild JJ, Salvesen G, Hefta SA, Thogersen IB, Rutherfurd S, Pizzo SV. Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-α-inhibitor. J Biol Chem 1991;266:747-51
9. 9 Mizon C, Balduyck M, Albani D, Michalski C, Burnouf T, Mizon J. Development of an enzyme-linked immunosorbent assay for human plasma inter-α-trypsin inhibitor (ITI) using specific antibodies against each of the H1 and H2 heavy chains. J Immunol Methods 1996;190:61-70
10. 10 Mizon C, Héron A, Capon C et al. Human pre-α-inhibitor: isolation from a by-product of industrial scale plasma fractionation and structural analysis of its H3 heavy chain. J Chromat B 1997;692:281-91
11. 11 Balduyck M, Hayem A, Kerckaert JP, Mizon C, Mizon J. Isolation of a human urinary trypsin inhibitor. Biochem Biophys Res Comm 1982;109:1247-55
12. 12 Cabanis A, Gressier B, Lebègue S et al. A rapid density gradient technique for separating polymorphonuclear granulocytes. APMIS 1994;102:119-21
13. 13 Perini JM, Mizon C, Dehon B et al. Urinary protein determination using Coomassie Brilliant Blue in the presence of sodium dodecyl sulphate. Clin Chim Acta 1984;143: 321-8
14. 14 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;48:617-20
15. 15 Gressier B, Balduyck M, Mizon C, Mizon J. Crossed immunoelectrophoresis does not allow accurate determination of inter-α-trypsin inhibitor and its derivatives in plasma. Biol Chem Hoppe-Seyler 1990;371:865-70
16. 16 Balduyck M, Laroui S, Mizon C, Mizon J. A proteoglycan related to the urinary trypsin inhibitor (UTI) links the two heavy chains of inter-α-trypsin inhibitor. Biol Chem Hoppe-Seyler 1989;370:329-36
17. 17 Blom AM, Thuveson M, Fries E. Intracellular coupling of bikunin and the heavy chain of rat pre-α-inhibitor in COS-1 cells. Biochem J 1997;328:185-91
18. 18 Martin-Vandelet N, Paris S, Bourguignon J, Sesboüé R, Martin JP, Diarra-Mehrpour M. Assembly and secretion of recombinant chains of human inter-α-trypsin inhibitor in COS-7 cells, Eur J Biochem 1999;259:476-84
19. 19 Carrette O, Mizon C, Balduyck M, Jourdain M, Fourrier F, Mizon J. Pig IαI appears unmodified in plasma in case of endotoxin-induced disseminated intravascular coagulation. Biochimie 1997;79:749-55
20. 20 Balduyck M, Piva F, Mizon C et al. Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-α-trypsin inhibitor (ITI). Biol Chem Hoppe-Seyler 1993;374:895-901
21. 21 Diarra-Mehrpour M, Sarafan N, Bourguignon J, Bonnet F, Bost F, Martin JP. Human inter-α-trypsin inhibitor heavy chain H3 gene; genomic organization, promoter analysis and gene linkage. J Biol Chem 1998;273:26809-19
22. 22 Bos R, Van Leuven CJM, Stolk J, Hiemstra PS, Ronday HK, Nieuwenhuizen W. An enzyme-immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis. Eur J Clin Invest 1997;27:148-56
23. 23 Hastka J. The importance of granulocyte elastase in haematological diagnosis. Blut 1988;57:69-75
24. 24 Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ. Cell-surface-bound elastase and cathepsin G on human neutrophils: a novel non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine-proteinases. J Cell Biol 1995;131:775-89
25. 25 Törnebohm E, Egberg N, Sablica H, Wallin R, Lockner D, Paul C. Elastase activity in leukaemic cells and plasma in patients with acute leukaemia. Eur J Haematol 1992;9:98-104.